Page last updated: 2024-10-31

clorgyline and Cerebrovascular Disorders

clorgyline has been researched along with Cerebrovascular Disorders in 2 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nakamura, S1
Akiguchi, I1
Kimura, J1
Senjo, M1
Yamazaki, N1
Minami, M1
Hirokami, M1
Saito, H1
Parvez, H1

Other Studies

2 other studies available for clorgyline and Cerebrovascular Disorders

ArticleYear
The histochemical demonstration of MPTP oxidation in the postmortem human striatum.
    Neuroscience letters, 1993, May-14, Volume: 154, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Aged, 80 and over; Caudate Nucleus; Cerebrovascu

1993
Decreased monoamine oxidase activity in stroke-prone spontaneously hypertensive rat kidneys.
    Research communications in chemical pathology and pharmacology, 1986, Volume: 52, Issue:2

    Topics: Animals; Cerebrovascular Disorders; Clorgyline; Hypertension; In Vitro Techniques; Kidney; Mitochond

1986